Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective ...

Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...

InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...

Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...

Gore & Associates announced that its Excluder thoracoabdominal branch endoprosthesis (TAMBE) received CE Mark approval earlie ...

In this retrospective analysis, Zil-E-Ali et al found that patients with government-funded insurance who underwent urgent or ...

VIRad.AI announced the launch of its artificial intelligence (AI)–powered clinical decision support platform, designed spec ...

Rapid Medical announced FDA clearance of the Tigertriever 25 thrombectomy device. Additionally, the company announced that the fi ...

The results from the OCEANIC-STROKE study were published by Mukul Sharma, MD, et al in The New England Journal of Medicine (NEJM; ...

Stereotaxis, a St. Louis, Missouri–based company focused on robotics for endovascular intervention, announced that it has e ...

Translating the 2026 PE guideline recommendations into practice to enhance decision-making, streamline care pathways, and ...